← Back to Search

Procedure

A Multicenter Clinical Study of the Sonablate®450 for the TreAtment of Locally Recurrent Prostate Cancer With HIFU (STAR Trial) (STAR Trial)

N/A
Waitlist Available
Research Sponsored by SonaCare Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a treatment that uses focused sound waves to destroy prostate cancer cells in men whose cancer has returned after radiation therapy. The sound waves heat and kill the cancer cells without surgery. This is an emerging minimally invasive treatment option for prostate cancer.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: HIFUExperimental Treatment1 Intervention
High Intensity Focused Ultrasound
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
High Intensity Focused Ultrasound
2006
Completed Phase 2
~90

Find a Location

Who is running the clinical trial?

SonaCare MedicalLead Sponsor
6 Previous Clinical Trials
560 Total Patients Enrolled
3 Trials studying Prostate Cancer
486 Patients Enrolled for Prostate Cancer
Mark Carol, MDStudy DirectorSonaCare Medical, LLC
~7 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top